On November 18, 2021, the large-scale peptide raw material drug project construction and innovative drug signing ceremony of Space Peptides (Taizhou) were grandly held in Taixing Economic Development Zone.
Space Peptides (Taizhou) peptide APIs Project is invested and constructed by Space Peptides Pharmaceutical Co., Ltd. with a total investment of 1.03 billion RMB, covering an area of 80000 square meter, to build workshops for the production of high value-added peptide APIs. It is mainly an extension of the large-scale production of innovative peptide drugs, involving fields such as anti drug resistant bacteria, antiviral, anti rheumatoid, anticoagulant, diabetes treatment, assisted reproduction, etc.
Space Peptides provides one-stop platform services for peptide drugs, from new drug discovery (CRO) to industrial production (CMO/CDMO). At present, the company has formed innovative drug pipelines in many fields, such as antibacterial peptides, ophthalmic drugs, anti COVID-19 fusion inhibitors, anti coagulation, anti HIV and so on. At the same time, we will establish a multi product and multi business cooperation model with large pharmaceutical companies both domestically and internationally. Space Peptides(Taizhou), relying on its core competitiveness in innovative drugs, will build a CDMO intelligent chemical plant in Taixing with green and low-carbon production technology and high value-added peptide raw material products.
